Researchers identified a total of 1987 injury events across medication groups, with fractures being the most common injury event (923 cases), followed by falls leading to fracture (773 cases), and ...

The approval was based upon a bioavailability study in healthy adults comparing baclofen oral tablets to Lyvispah. Amneal has announced the launch of Lyvispah ® (baclofen) oral granules for the ...

Lyvispah is supplied as a strawberry-flavored, dissolvable granular formulation of baclofen. The Food and Drug Administration (FDA) has approved Lyvispah™ (baclofen) oral granules for the treatment of ...

Amneal is set to acquire specialty pharmaceutical company Saol Therapeutics’ Baclofen franchise, including Lioresal and Lyvispah, as well as a pipeline product under development. The acquisition ...

Amneal is unveiling two generic products. The company is offering Lyvispah, a baclofen oral granules specialty product approved by the Food and Drug Administration for the treatment of spasticity ...

The market for novel formulations of baclofen is heating up. Weeks after Saol Therapeutics won approval for its strawberry-flavored oral granules, Azurity Pharmaceuticals has received FDA ...